HAE News Alert Haemonetics Corp (HAE) 37.03 12/16/2014 21:24

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Haemonetics Corp (HAE) 37.03 $HAE

Haemonetics (HAE) Upgraded From Hold to Buy
at The Street - Sat Dec 13, 7:20AM CST
Haemonetics (HAE) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. 
HAE: 37.03 (+0.53)

Post Earnings Update: Haemonetics Has Climbed 6.9% Higher in Past 2 Weeks (HAE)
Comtex SmarTrend(R) - Mon Nov 17, 8:53AM CST
When Haemonetics (NYSE:HAE) reported earnings 14 days ago on November 3rd, 2014, analysts, on average, expected the company to report earnings of $0.45 on sales of $230.0 million. The company actually reported EPS of $0.47 on sales of $227.6 million, beating EPS estimates by $0.02 and missing revenue estimates by $2.4 million. Shares of Haemonetics have climbed from $34.74 to $37.13, representing a gain of 6.9% since the company reported earnings 14 days ago.
HAE: 37.03 (+0.53)

Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference
PR Newswire - Tue Nov 11, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President, Investor Relations, will present at the Jefferies 2014 Global Healthcare Conference in London, England on November 20, 2014 at 8:40 am GMT.
HAE: 37.03 (+0.53)

Update: Haemonetics Needs A Sales Growth Infusion Following Q3 Sales Miss And EPS Beat
Martin Vlcek - at Seeking Alpha - Wed Nov 05, 8:56AM CST

HAE: 37.03 (+0.53)

NYSE stocks posting largest percentage decreases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
TLM.TO: 8.84 (+2.87), HLF: 37.36 (+0.20), FRM: 7.08 (-0.31), TLM: 7.58 (+2.46), AKS: 5.24 (+0.02), CIE: 7.78 (+0.15), RCAP: 10.90 (+0.44), GDP: 4.14 (+0.09), LRE: 7.06 (+0.21), HAE: 37.03 (+0.53), S: 3.81 (-0.24), SGY: 14.58 (+1.34), BAS: 5.74 (+0.38), GVA: 35.91 (+0.19), HELI: 3.73 (+0.09), AP: 17.49 (-0.13), CRK: 5.54 (+0.33)

Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 12.95 (+0.15), ICUI: 80.40 (+0.08), ABAX: 56.69 (+0.47), HAE: 37.03 (+0.53)

Haemonetics' (HAE) CEO Brian Concannon on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 10:42AM CST

HAE: 37.03 (+0.53)

Haemonetics affirms revenue and earnings guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 6:54AM CST

HAE: 37.03 (+0.53)

Haemonetics beats 2Q profit forecasts
Automated Insights - Mon Nov 03, 5:18AM CST
BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Monday reported fiscal second-quarter earnings of $7.5 million.
HAE: 37.03 (+0.53)

Haemonetics beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:02AM CST

HAE: 37.03 (+0.53)

Haemonetics Reports 2nd Quarter Fiscal 2015 Revenue of $228 Million and Adjusted EPS of $0.47; Reaffirms Revenue and Earnings Guidance
PR Newswire - Mon Nov 03, 5:00AM CST
Haemonetics Corporation (NYSE: HAE) today reported second quarter fiscal 2015 revenue of $227.6 million, down 3.5%. In constant currency, revenue declined 2.6% in the quarter. The Company reported second quarter GAAP net income of $7.5 million and GAAP net income per share of $0.14. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $24.3 million and adjusted earnings per share were $0.47, both down 29%.[1]
HAE: 37.03 (+0.53)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST

ACW: 4.38 (-0.16), SYY: 39.73 (+0.13), L: 39.07 (-0.38), EEP: 36.84 (-0.38), SNH: 21.53 (-0.27), INN: 11.71 (+0.09), ITG: 19.41 (+0.03), NSP: 31.73 (+0.52), S: 3.81 (-0.24), ALE: 52.09 (+0.13), GVA: 35.91 (+0.19), MCY: 54.55 (+0.32), ARNA: 3.78 (+0.06), CHD: 75.83 (-0.10), ARE: 87.27 (+0.51), USAK: 22.57 (-0.20), BWP: 16.37 (+0.43), KRG: 27.45 (unch), CYOU: 25.29 (+1.20), MNKD: 5.10 (-0.03), HNT: 50.63 (-0.68), AMH: 16.76 (-0.13), ARCB: 43.10 (-1.02), ANIP: 55.08 (+1.32), AMG: 189.53 (-3.73), HAE: 37.03 (+0.53), SOHU: 48.81 (+0.05), CNA: 37.11 (+0.06)

Haemonetics reports November 3
Seeking Alpha - at Seeking Alpha - Sat Nov 01, 4:46PM CDT

HAE: 37.03 (+0.53)

Is Haemonetics (HAE) Poised to Beat on Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:15PM CDT
Haemonetics (HAE) has delivered positive earnings surprises in three of the past four quarters with an average beat of 1.9%
HAE: 37.03 (+0.53), HTWR: 69.43 (-0.88), HOLX: 25.64 (+0.05), HSP: 58.82 (-1.52)

3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics' Donor Management System
Business Wire - Tue Oct 21, 7:49AM CDT
3PEA International, Inc. (OTCBB:TPNL)(OTCQB:TPNL), a vertically integrated provider of innovative prepaid card programs and processing services for corporate, consumer and government applications, today announced that 3PEA and Haemonetics Corporation (NYSE:HAE) have entered into an agreement whereby 3PEA International will integrate its PaySign(R) Connect prepaid debit card solution with Haemonetics' Donor Management System ("DMS" . The integration will allow users of the Haemonetics DMS to use the PaySign Connect payment solution for the plasma industry. This partnership will bring together the best of both worlds, the industry leading Haemonetics Donor Management System and 3PEA's PaySign(R) Connect, an intuitive, easy-to-use, fully tokenized payment system tailored to the unique requirements of the plasma collection industry.
HAE: 37.03 (+0.53)

Haemonetics Sets Date for Second Quarter Fiscal Year 2015 Earnings Release: November 3, 2014
PR Newswire - Mon Oct 06, 3:00PM CDT
Haemonetics Corporation (NYSE:HAE) will announce its earnings for the second quarter of its fiscal year 2015 on November 3, 2014 in a pre-market press release. The Company will host a webcast to discuss and answer questions about the press release at 8:00 am eastern time on November 3, 2014.
HAE: 37.03 (+0.53)

Perrigo Sells Some Assets to Imago Pharmaceuticals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 3:45PM CDT
Perrigo (PRGO) has out licensed some of its early-stage assets.
BIIB: 325.13 (-10.67), PRGO: 153.77 (-0.43), ABAX: 56.69 (+0.47), HAE: 37.03 (+0.53)

Walgreens Earnings in Line, Alliance Boots Shows Synergy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 9:45AM CDT
Walgreen Co. (WAG) reported adjusted net earnings of 74 cents per share in the fourth quarter of fiscal 2014.
ABAX: 56.69 (+0.47), HAE: 37.03 (+0.53), CVS: 92.31 (+2.44), WAG: 72.39 (-1.05)

Data Intensity Fortifies Track Record of Success in Oracle EBS R12 Implementations and Upgrades
PR Newswire - Tue Sep 23, 8:30AM CDT
Data Intensity, the industry leader in managed and cloud services for Oracle technologies and applications, today announced a significant milestone in the company's rich history of driving implementations and upgrades to Oracle E-Business Suite (EBS) Release 12 (R12) for its global customers. Data Intensity is celebrating the inception of its dedicated application engineering team, established five years ago this month to address the market need for expertise in planning, managing and executing on the most complex Oracle projects. The team also recently completed one of its most challenging upgrades to date for Haemonetics Corp, a global healthcare company that provides innovative blood management solutions. This deployment was one of ten R12 projects Data Intensity has delivered successfully this year, and the most recent of the 70+ R12-focused engagements the team has completed since the technology's release in 2007.
HAE: 37.03 (+0.53)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Obeng Joins WellcomeMD with Special Offer for Patients

Updated Category News Views 47

New Beginnings in Concierge Medicine In late October, WellcomeMD opened its doors to Dr. Paa-Kofi Obeng—an arrival greeted with considerable anticipation in Richmond's medical scene. This isn't just any run-of-the-mill staff addition; Dr. Obeng brings with him over a decade of experience from places like the Veterans Administration Medical Center. He's armed with a...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 56

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 142

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Clinch Scores Big with Two Prestigious Industry Honors

Updated Category News Views 101

Clinch's Dual Triumph in Advertising Innovation No one throws a ticker symbol over their cereal for recognizing brilliance, but when an outfit like Clinch gets double applause at the big dance, even we old-timers have to tip our hats. On November 16, 2026, the advertising world saw some fireworks. Clinch took home not one but two hefty awards—the kind that say you've...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 93

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 150

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 92

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating the Growth of the Digital Signage Market Today

Updated Category News Views 84

The digital signage market was transforming fast, with projections showing a jump from USD 20.1 billion in 2024 to around USD 27.3 billion by 2029—talk about a solid compound annual growth rate of 6.3%. Traders were buzzing over the factors driving this upward trend: high-res displays and expanding infrastructure in emerging markets had everyone seeing green. Market...

Continue Reading
Exploring the Potential of Healthcare Stocks Amid Market Growth

Updated Category News Views 189

The stock market is navigating through exciting times, with the S&P 500 recently eclipsing the significant milestone of 5,700 points. This robust performance is fueled by a dynamic shift as investors increasingly look towards emerging sectors, particularly healthcare, which is gaining momentum this earnings season. This year, we've seen an impressive trend, with over 40...

Continue Reading
Recognizing Excellence: Nominate for the Paralegal of the Year Award

Updated Category News Views 217

Nominations Now Open for the 2025 AAJ Paralegal of the Year Award The American Association for Justice (AAJ) proudly announces that nominations for the 2025 Paralegal of the Year Award are now open. This award, sponsored by Advocate Capital, Inc., is a wonderful opportunity to acknowledge and applaud the significant contributions of paralegals within our civil justice...

Continue Reading
Mavsign and RouteOne Revolutionize Automotive Deal Processes

Updated Category News Views 174

Mavsign and RouteOne Transforming Automotive Transactions Mavsign, renowned for its expertise in remote document signings and compliance solutions, has announced an exciting partnership with RouteOne, a leader in automotive financing solutions. This collaboration aims to enhance the efficiency and security of automotive transactions by integrating both companies'...

Continue Reading
Revance Stockholders Encouraged to Support Crown's Tender Offer

Updated Category News Views 122

Crown's Tender Offer for Revance Stock: Key Information Revance Therapeutics, Inc. (NASDAQ: RVNC) stockholders are being urged to support Crown Laboratories, Inc. by tendering their shares before the upcoming deadline. This is an important moment as Crown's tender offer presents the only current proposal post Teoxane's withdrawal. Details of the Crown Offer Crown has made...

Continue Reading